🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Proteinuric Renal Disease

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases NCT07614477Phase 22 sites📍 Beijing📍 Tianjin Everest Medicines (China) Co.,Ltd. · Tests: EVER001 A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease NCT06830629Phase 279 sites📍 Decatur📍 Huntsville📍 Montgomery Maze Therapeutics · Tests: MZE829 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease NCT07355296Phase 2159 sites📍 Huntsville📍 Glendale📍 Granada Hills Boehringer Ingelheim · Tests: BI 764198, Placebo matching BI 764198 Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases NCT05003986Phase 247 sites📍 Los Angeles📍 Wilmington📍 Miami Travere Therapeutics, Inc. · Tests: Sparsentan, Sparsentan, Sparsentan Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria NCT07224776Phase 11 site📍 Boston Brigham and Women's Hospital · Tests: sparsentan, No sparsentan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy